Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis

OBJECTIVE: It is unknown whether there are differences in efficacy and safety between quetiapine extended‐release, 300 mg/d (QUEXR300), and olanzapine, 5‐20 mg/d (OLA), for Japanese patients with bipolar depression. METHODS: We conducted a Bayesian analysis of data from phase 3 studies in Japan of Q...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Ikuta, Toshikazu, Matsuda, Yuki, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Micro Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292317/
https://www.ncbi.nlm.nih.gov/pubmed/31283865
http://dx.doi.org/10.1002/npr2.12070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292317/
https://www.ncbi.nlm.nih.gov/pubmed/31283865
http://dx.doi.org/10.1002/npr2.12070

Ejemplares similares